BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2342174)

  • 1. Intracavernous injection therapy: analysis of results and complications.
    Lakin MM; Montague DK; VanderBrug Medendorp S; Tesar L; Schover LR
    J Urol; 1990 Jun; 143(6):1138-41. PubMed ID: 2342174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection.
    Hu KN; Burks C; Christy WC
    J Urol; 1987 Aug; 138(2):404-5. PubMed ID: 2439714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How safe is the treatment of impotence with intracavernous autoinjection?
    Zentgraf M; Ludwig G; Ziegler M
    Eur Urol; 1989; 16(3):165-71. PubMed ID: 2663519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
    Stief CG; Wetterauer U; Kulvelis F; Popken G; Staubesand J; Sommerkamp H
    Urol Int; 1990; 45(6):321-5. PubMed ID: 2288047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic.
    Armstrong DK; Convery A; Dinsmore WW
    Int J STD AIDS; 1993; 4(4):214-6. PubMed ID: 8399501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
    Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
    JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracavernous pharmacotherapy for organic impotence in the elderly].
    Richter S; Shalev M; Nissenkorn I
    Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
    Girdley FM; Bruskewitz RC; Feyzi J; Graversen PH; Gasser TC
    J Urol; 1988 Nov; 140(5):972-4. PubMed ID: 3172370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine.
    Zentgraf M; Baccouche M; Jünemann KP
    Urol Int; 1988; 43(2):65-75. PubMed ID: 3291360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priapism: an avoidable complication of pharmacologically induced erection.
    Fouda A; Hassouna M; Beddoe E; Kalogeropoulos D; Binik YM; Elhilali MM
    J Urol; 1989 Oct; 142(4):995-7. PubMed ID: 2795759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Priapism induced by intracavernous injection].
    Morales Concepción JC
    Arch Esp Urol; 1992 Oct; 45(8):793-5. PubMed ID: 1466580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of fibrotic penile lesions secondary to the intracorporeal injection of vasoactive agents.
    Corriere JN; Fishman IJ; Benson GS; Carlton CE
    J Urol; 1988 Sep; 140(3):615-7. PubMed ID: 3411687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM; Stevenson RW; Szasz G
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
    Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologically induced erections among geriatric men.
    Kerfoot WW; Carson CC
    J Urol; 1991 Oct; 146(4):1022-4. PubMed ID: 1895417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.